Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Technetium-99m sulfur colloid + methylene blue is a combination used for sentinel lymph node biopsy procedures, particularly in breast cancer and melanoma patients. The technetium-99m sulfur colloid component is a radioactive diagnostic agent that localizes in lymph nodes draining a primary tumor, while methylene blue is a vital blue dye that provides visual identification of lymph nodes. This dual-tracer approach enhances the ability to detect sentinel lymph nodes during surgery. The radioactive component emits gamma radiation at 140 keV with a physical half-life of approximately 6 hours, allowing detection with a hand-held gamma counter, while the blue dye enables visual identification of nodes during surgery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on technetium-99m sulfur colloid + methylene blue.